Delivery Order SPE2DR25D7062-SPE2DR26FX0EV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,668.69 to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (2 units) on September 23, 2025, with completion due by September 24, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion and active through December 2026. The place of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,143.28 for Narcan 4 mg nasal spray (2-count units) on June 18, 2025, with completion targeted for June 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a discrete fulfillment under AmerisourceBergen's broader pharmaceutical supply infrastructure...
- The Defense Logistics Agency awarded a delivery order valued at $1,594.44 to AmerisourceBergen Drug Corp for Narcan 4 mg nasal spray (2-pack units) on October 30, 2025, with an ultimate completion date of October 31, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract leverages AmerisourceBergen's established Indefinite Delivery Contract (IDC)...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Narcan 4 mg nasal spray (two-count packages) with a ceiling value of $3,574.16. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 8, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (2-pack units) under a firm fixed-price contract with a ceiling value of $5,631.58. The delivery order was competitively awarded without set-aside provisions and carries an ultimate completion date of January 13, 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on July 10, 2025, for the supply of Narcan 4 mg nasal spray (2 units) with a contract value of $1,183.00. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania, and scheduled for completion by July 11, 2025. The award represents a competitive procurement under AmerisourceBergen's existing Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $2,449.20 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 19, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency has awarded a delivery order valued at $8,505.57 to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (2-pack units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was utilized for this procurement. This delivery order is issued under AmerisourceBergen Drug Corp's...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 1, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units) valued at $3,391.20 with an ultimate completion date of September 2, 2025. This is a firm fixed price, non-set-aside contract issued by the Medical Supply Chain, a division of the Defense Logistics Agency supporting the Department of Defense. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,841.52 to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (2-pack units) with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will perform...
- SPE2DR25D7062Indefinite Delivery Contract
- SPE2DR25D7062-SPE2DR26FX0EVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,469.55 to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (two-pack units) on January 28, 2026, with completion expected by February 25, 2026. This firm fixed-price, non-set-aside contract was performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 vehicle running through December 2031 that supports comprehensive pharmaceutical supply to military healthcare programs globally. AmerisourceBergen serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio encompasses a wide range of pharmaceutical products, medical devices, and healthcare commodities across multiple therapeutic domains. This Narcan delivery order exemplifies the company's role in supplying emergency medical products required by government healthcare institutions. As a major pharmaceutical distributor, AmerisourceBergen competes on a full and open basis for federal contracts, demonstrating consistent capability to meet DLA's medical supply chain requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 1/27/26 |